Connacht Asset Management LP Cytokinetics Inc Transaction History

Connacht Asset Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $11,873 - $14,833	364 Added 5.3%	7,238 $236,000
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $12,476 - $17,095	374 Added 5.75%	6,874 $241,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $28,472 - $40,683	796 Added 13.96%	6,500 $297,000
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $3,430 - $4,852	89 Added 1.59%	5,704 $276,000
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $60,225 - $86,833	-1,775 Reduced 24.02%	5,615 $221,000
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $137,606 - $212,842	-4,627 Reduced 38.5%	7,390 $272,000
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $412,783 - $557,348	12,017 New	12,017 $548,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.